OM
FOMX
Opaleye Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-180,000
| Closed | -$675K | – | 59 |
|
|
2019
Q1 | $675K | Buy |
+180,000
| New | +$675K | 0.19% | 50 |
|
|
2018
Q4 | – | Sell |
-91,000
| Closed | -$521K | – | 59 |
|
|
2018
Q3 | $521K | Sell |
91,000
-159,000
| -64% | -$910K | 0.13% | 46 |
|
|
2018
Q2 | $3.83M | Sell |
250,000
-700,000
| -74% | -$10.7M | 0.99% | 30 |
|
|
2018
Q1 | $4.87M | Sell |
950,000
-10,000
| -1% | -$51.3K | 1.39% | 22 |
|
|
2017
Q4 | $5.77M | Sell |
960,000
-182,000
| -16% | -$1.09M | 1.85% | 18 |
|
|
2017
Q3 | $6.34M | Buy |
1,142,000
+7,000
| +0.6% | +$38.8K | 2.24% | 15 |
|
|
2017
Q2 | $5.27M | Buy |
1,135,000
+635,000
| +127% | +$2.95M | 2.2% | 15 |
|
|
2017
Q1 | $2.48M | Buy |
500,000
+5,000
| +1% | +$24.8K | 1.23% | 26 |
|
|
2016
Q4 | $5.5M | Sell |
495,000
-135,000
| -21% | -$1.5M | 3.24% | 6 |
|
|
2016
Q3 | $5.83M | Sell |
630,000
-65,000
| -9% | -$602K | 3.05% | 7 |
|
|
2016
Q2 | $4.41M | Buy |
695,000
+105,000
| +18% | +$667K | 2.95% | 11 |
|
|
2016
Q1 | $3.85M | Buy |
590,000
+90,000
| +18% | +$587K | 2.4% | 18 |
|
|
2015
Q4 | $4.06M | Buy |
500,000
+215,000
| +75% | +$1.74M | 1.7% | 26 |
|
|
2015
Q3 | $2.09M | Buy |
285,000
+200,000
| +235% | +$1.47M | 1.03% | 37 |
|
|
2015
Q2 | $871K | Buy |
+85,000
| New | +$871K | 0.35% | 41 |
|